Maximus, Inc. (MMS) Director Sells $96,450.00 in Stock

Maximus, Inc. (NYSE:MMS) Director Russell A. Beliveau sold 1,500 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $64.30, for a total transaction of $96,450.00. Following the transaction, the director now owns 40,329 shares in the company, valued at $2,593,154.70. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Maximus, Inc. (NYSE MMS) traded down $0.15 during trading hours on Friday, reaching $65.47. 327,295 shares of the company were exchanged, compared to its average volume of 297,133. Maximus, Inc. has a 1 year low of $51.74 and a 1 year high of $66.96. The stock has a market cap of $4,243.90, a price-to-earnings ratio of 21.05, a price-to-earnings-growth ratio of 2.44 and a beta of 1.32.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Investors of record on Wednesday, November 15th will be given a $0.045 dividend. The ex-dividend date is Tuesday, November 14th. This represents a $0.18 dividend on an annualized basis and a yield of 0.27%. Maximus’s dividend payout ratio (DPR) is 5.66%.

WARNING: This piece was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://sportsperspectives.com/2017/11/19/maximus-inc-mms-director-sells-96450-00-in-stock.html.

A number of large investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Maximus by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock valued at $355,052,000 after buying an additional 130,839 shares during the last quarter. FMR LLC lifted its holdings in Maximus by 10.4% in the second quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock valued at $291,767,000 after acquiring an additional 438,025 shares during the period. Victory Capital Management Inc. lifted its holdings in Maximus by 13.3% in the third quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock valued at $226,667,000 after acquiring an additional 413,325 shares during the period. Janus Henderson Group PLC lifted its holdings in Maximus by 718.8% in the second quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock valued at $138,515,000 after acquiring an additional 1,941,521 shares during the period. Finally, State Street Corp lifted its holdings in Maximus by 3.5% in the second quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock valued at $133,906,000 after acquiring an additional 71,823 shares during the period. Hedge funds and other institutional investors own 97.55% of the company’s stock.

A number of equities analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Maximus from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Maxim Group set a $66.00 target price on shares of Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. Canaccord Genuity lowered their target price on shares of Maximus from $62.00 to $61.00 and set a “hold” rating on the stock in a research report on Friday, November 10th. BidaskClub lowered shares of Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Robert W. Baird reiterated a “hold” rating and issued a $64.00 price objective on shares of Maximus in a research report on Friday, September 1st. Two research analysts have rated the stock with a sell rating and six have given a hold rating to the company. The company currently has an average rating of “Hold” and an average target price of $64.33.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply